Antagonist anti-IL-7 receptor antibodies and methods

Details for Australian Patent Application No. 2011219488 (hide)

Owner Rinat Neuroscience Corporation

Inventors Lin, Chia-Yang; Lee, Li-Fen; Zhai, Wenwu

Agent Davies Collison Cave

Pub. Number AU-A-2011219488

PCT Pub. Number WO2011/104687

Priority 61/307,670 24.02.10 US; 61/438,205 31.01.11 US

Filing date 24 February 2011

Wipo publication date 1 September 2011

International Classifications

C07K 16/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61P 3/10 Drugs for disorders of the metabolism

A61P 37/00 Drugs for immunological or allergic disorders

A61P 37/06 Drugs for immunological or allergic disorders

C12N 15/13 Mutation or genetic engineering - Immunoglobulins

Event Publications

23 August 2012 PCT application entered the National Phase

  PCT publication WO2011/104687 Priority application(s): WO2011/104687

13 September 2012 Alteration of Name

  The name of the applicant has been altered to Rinat Neuroscience Corp.

25 October 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 28 Sep 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011219494-A porous ABPBI (Phosphoric Acid Doped Poly (2,5-benzimidazole)) membrane and process of preparing the same

2011219481-A composition for treating AIDS and associated conditions